New research reveals significant differences in gene expression related to metabolism, inflammation and cardioprotection in the fat tissue of lean and obese mice. These findings could advance the development of targeted therapies ...
1 hour ago
0
0
Having a quality breakfast that provides the right amount of energy to face the day, around a quarter of daily intake, reduces the risk of cardiovascular disease.
Dec 11, 2024
0
2
Postprandial hypoglycemia is one of the main complications of bariatric surgery and can affect up to 30% of patients. Unlike ordinary hypoglycemia, in which low blood sugar is usually associated with little food, postprandial ...
Dec 10, 2024
1
2
Researchers from the Granada Biosanitary Research Institute and the University of Granada have revealed positive and negative associations between exposure to a combination of different metals and overweight and obesity in ...
Dec 10, 2024
0
0
Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional—and often ineffective—advice to "eat less and exercise more."
Dec 9, 2024
0
0
After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets don't work.
Dec 9, 2024
0
0
The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs' cost should be covered by Medicare, Medicaid and private insurers.
Dec 5, 2024
0
0
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.
Dec 4, 2024
0
1
A study in Brazil involving 89 father-mother-baby triads points to an association between paternal overweight and newborn birth weight: the higher the father's body mass index (BMI, weight divided by height squared), the ...
Dec 4, 2024
0
0
About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 (GLP-1) receptor agonists and GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists ...
Dec 3, 2024
0
0
